2023
Liew, F., Talwar, S., Cross, A., Willett, B. J., Scott, S., Logan, N., . . . PHOSP-COVID collaborative group. (2022). SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.. EBioMedicine, 104402. doi:10.1016/j.ebiom.2022.104402DOI: 10.1016/j.ebiom.2022.104402
2022
Stewart, I., Jacob, J., George, P. M., Molyneaux, P. L., Porter, J. C., Allen, R. J., . . . Jenkins, R. G. (2022). Residual Lung Abnormalities Following COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID Study.. American journal of respiratory and critical care medicine. doi:10.1164/rccm.202203-0564ocDOI: 10.1164/rccm.202203-0564oc
van der Feltz-Cornelis, C. M., Sweetman, J., Allsopp, G., Attree, E., Crooks, M. G., Cuthbertson, D. J., . . . STIMULATE-ICP Consortium. (2022). STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol.. PloS one, 17(11), e0277936. doi:10.1371/journal.pone.0277936DOI: 10.1371/journal.pone.0277936
Vink, E., Davis, C., MacLean, A., Pascall, D., McDonald, S. E., Gunson, R., . . . Ho, A. (2022). Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study. OPEN FORUM INFECTIOUS DISEASES, 9(11). doi:10.1093/ofid/ofac531DOI: 10.1093/ofid/ofac531
Siggins, M. K., Davies, K., Fellows, R., Thwaites, R. S., Baillie, J. K., Semple, M. G., . . . ISARIC4C Investigators. (2022). Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.. Immunology. doi:10.1111/imm.13585DOI: 10.1111/imm.13585
Evans, R. A., Leavy, O. C., Richardson, M., Elneima, O., McAuley, H. J. C., Shikotra, A., . . . Brightling, C. E. (2022). Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. LANCET RESPIRATORY MEDICINE, 10(8), 761-775. doi:10.1016/S2213-2600(22)00127-8DOI: 10.1016/S2213-2600(22)00127-8
Ramasawmy, M., Mu, Y., Clutterbuck, D., Pantelic, M., Lip, G. Y. H., van der Feltz-Cornelis, C., . . . STIMULATE-ICP Consortium. (2022). STIMULATE-ICP-CAREINEQUAL (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) study protocol: Defining usual care and examining inequalities in Long Covid support.. PloS one, 17(8), e0271978. doi:10.1371/journal.pone.0271978DOI: 10.1371/journal.pone.0271978
RECOVERY Collaborative Group. (2022). Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.. Lancet (London, England), 400(10349), 359-368. doi:10.1016/s0140-6736(22)01109-6DOI: 10.1016/s0140-6736(22)01109-6
Plekhanova, T., Rowlands, A. V., Evans, R. A., Edwardson, C. L., Bishop, N. C., Bolton, C. E., . . . Yates, T. (2022). Device-assessed sleep and physical activity in individuals recovering from a hospital admission for COVID-19: a multicentre study. INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY, 19(1). doi:10.1186/s12966-022-01333-wDOI: 10.1186/s12966-022-01333-w
Phillips, E., Adele, S., Malone, T., Deeks, A., Stafford, L., Dobson, S. L., . . . Dunachie, S. J. (2022). Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naive and convalescent healthcare workers. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. doi:10.1093/cei/uxac042DOI: 10.1093/cei/uxac042
Narhi, F., Moonesinghe, S. R., Shenkin, S. D., Drake, T. M., Mulholland, R. H., Donegan, C., . . . Docherty, A. B. (2022). Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study. LANCET DIGITAL HEALTH, 4(4). Retrieved from https://www.webofscience.com/
RECOVERY Collaborative Group. (2022). Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.. Lancet (London, England), 399(10325), 665-676. doi:10.1016/s0140-6736(22)00163-5DOI: 10.1016/s0140-6736(22)00163-5
Dejnirattisai, W., Huo, J., Zhou, D., Zahradník, J., Supasa, P., Liu, C., . . . Screaton, G. R. (2022). SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.. Cell, 185(3), 467-484.e15. doi:10.1016/j.cell.2021.12.046DOI: 10.1016/j.cell.2021.12.046
RECOVERY Collaborative Group. (2022). Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.. Lancet (London, England), 399(10320), 143-151. doi:10.1016/s0140-6736(21)01825-0DOI: 10.1016/s0140-6736(21)01825-0
Angyal, A., Longet, S., Moore, S. C., Payne, R. P., Harding, A., Tipton, T., . . . de, S. T. I. (2022). T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study. LANCET MICROBE, 3(1), E21-E31. doi:10.1016/S2666-5247(21)00275-5DOI: 10.1016/S2666-5247(21)00275-5
2021
de, S. T. I., Liu, G., Lindsey, B. B., Dong, D., Moore, S. C., Hsu, N. S., . . . Dong, T. (2021). The impact of viral mutations on recognition by SARS-CoV-2 specific T cells. ISCIENCE, 24(11). doi:10.1016/j.isci.2021.103353DOI: 10.1016/j.isci.2021.103353
Payne, R. P., Longet, S., Austin, J. A., Skelly, D. T., Dejnirattisai, W., Adele, S., . . . Dunachie, S. (2021). Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. CELL, 184(23), 5699-+. doi:10.1016/j.cell.2021.10.011DOI: 10.1016/j.cell.2021.10.011
Evans, R. A., McAuley, H., Harrison, E. M., Shikotra, A., Singapuri, A., Sereno, M., . . . Brightling, C. E. (2021). Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. LANCET RESPIRATORY MEDICINE, 9(11), 1275-1287. doi:10.1016/S2213-2600(21)00383-0DOI: 10.1016/S2213-2600(21)00383-0
Wickenhagen, A., Sugrue, E., Lytras, S., Kuchi, S., Noerenberg, M., Turnbull, M. L., . . . Wilson, S. J. (2021). A prenylated dsRNA sensor protects against severe COVID-19. SCIENCE, 374(6567). doi:10.1126/science.abj3624DOI: 10.1126/science.abj3624
Wild, J. M., Porter, J. C., Molyneaux, P. L., George, P. M., Stewart, I., Allen, R. J., . . . Jenkins, R. G. (2021). Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID). BMJ Open Respiratory Research, 8(1), e001049. doi:10.1136/bmjresp-2021-001049DOI: 10.1136/bmjresp-2021-001049
Russell, C. D., Fairfield, C. J., Drake, T. M., Turtle, L., Seaton, R. A., Wootton, D. G., . . . Ho, A. (2021). Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. LANCET MICROBE, 2(8), E354-E365. doi:10.1016/S2666-5247(21)00090-2DOI: 10.1016/S2666-5247(21)00090-2
Drake, T. M., Riad, A. M., Fairfield, C. J., Egan, C., Knight, S. R., Pius, R., . . . Semple, M. G. (2021). Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. LANCET, 398(10296), 223-237. Retrieved from https://www.webofscience.com/
Horby, P. W., Landray, M. J., & Grp, R. E. C. O. V. E. R. Y. C. (2021). Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. LANCET, 397(10289), 2049-2059. doi:10.1016/S0140-6736(21)00897-7DOI: 10.1016/S0140-6736(21)00897-7
Horby, P. W., & Landray, M. J. (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. LANCET, 397(10285), 1637-1645. Retrieved from https://www.webofscience.com/
Dennis, A., Wamil, M., Alberts, J., Oben, J., Cuthbertson, D. J., Wootton, D., . . . Investigators, C. O. V. E. R. S. C. A. N. S. (2021). Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open, 11(3). doi:10.1136/bmjopen-2020-048391DOI: 10.1136/bmjopen-2020-048391
Dexamethasone in Hospitalized Patients with Covid-19 (Journal article)
Wootton, D., & The RECOVERY Collaborative Group. (2021). Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine, 384(8), 693-704. doi:10.1056/nejmoa2021436DOI: 10.1056/nejmoa2021436
Horby, P. W., Roddick, A., Spata, E., Staplin, N., Emberson, J., Pessoa-Amorim, G., . . . Yates, H. (2021). Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. LANCET, 397(10274), 605-612. doi:10.1016/S0140-6736(21)00149-5DOI: 10.1016/S0140-6736(21)00149-5
PREDICTORS OF AND TIME FRAME FOR READMISSION FOLLOWING HOSPITALISATION WITH COMMUNITY ACQUIRED PNEUMONIA (Conference Paper)
Chakrabarti, B., Lane, S., Jenks, T., Higgins, J., Kanwar, E., Allen, M., & Wootton, D. G. (2021). PREDICTORS OF AND TIME FRAME FOR READMISSION FOLLOWING HOSPITALISATION WITH COMMUNITY ACQUIRED PNEUMONIA. In THORAX Vol. 76 (pp. A61-A62). doi:10.1136/thorax-2020-BTSabstracts.106DOI: 10.1136/thorax-2020-BTSabstracts.106
2020
Bradley, P., Frost, F., Tharmaratnam, K., & Wootton, D. G. (2020). The utility of established prognostic scores in COVID-19 hospital admissions: a multi-centre prospective evaluation of CURB-65, NEWS2, and qSOFA. BMJ Open Respiratory Research, 7(1). doi:10.1101/2020.07.15.20154815DOI: 10.1101/2020.07.15.20154815
Bradley, P., Frost, F., Tharmaratnam, K., & Wootton, D. G. (2020). Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA. BMJ OPEN RESPIRATORY RESEARCH, 7(1). doi:10.1136/bmjresp-2020-000729DOI: 10.1136/bmjresp-2020-000729
Horby, P., Mafham, M., Linsell, L., Bell, J. L., Staplin, N., Emberson, J. R., . . . Landray, M. J. (2020). Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. NEW ENGLAND JOURNAL OF MEDICINE, 383(21), 2030-2040. doi:10.1056/NEJMoa2022926DOI: 10.1056/NEJMoa2022926
The challenge of antimicrobial prescribing for hospital-acquired pneumonia (Journal article)
Wootton, D., Aston, S., & Felton, T. (2020). The challenge of antimicrobial prescribing for hospital-acquired pneumonia. Journal of Hospital Infection, 104(2), 198-199. doi:10.1016/j.jhin.2019.11.002DOI: 10.1016/j.jhin.2019.11.002
Antimicrobial prescribing for hospital-acquired pneumonia. (Journal article)
Felton, T., & Wootton, D. (2020). Antimicrobial prescribing for hospital-acquired pneumonia.. British journal of hospital medicine (London, England : 2005), 81(1), 1-3. doi:10.12968/hmed.2019.0325DOI: 10.12968/hmed.2019.0325
2019
PREDICTORS OF 30 DAY READMISSION FOLLOWING HOSPITALIZATION WITH COMMUNITY ACQUIRED PNEUMONIA (Conference Paper)
Chakrabarti, B., Jenks, T., Lane, S., Higgins, J., Kanwar, E., & Wootton, D. G. (2019). PREDICTORS OF 30 DAY READMISSION FOLLOWING HOSPITALIZATION WITH COMMUNITY ACQUIRED PNEUMONIA. In THORAX Vol. 74 (pp. A68). doi:10.1136/thorax-2019-BTSabstracts2019.113DOI: 10.1136/thorax-2019-BTSabstracts2019.113
Community-acquired pneumonia due to drug-resistant Enterobacteriaceae: A global perspective (Journal article)
Aston, S. J., & Wootton, D. G. (2019). Community-acquired pneumonia due to drug-resistant Enterobacteriaceae: A global perspective. Respirology. doi:10.1111/resp.13720DOI: 10.1111/resp.13720
Wootton, D. G., Cox, M. J., Gloor, G. B., Litt, D., Hoschler, K., German, E., . . . Gordon, S. B. (2019). A Haemophilus sp. dominates the microbiota of sputum from UK adults with non-severe community acquired pneumonia and chronic lung disease. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-018-38090-5DOI: 10.1038/s41598-018-38090-5
2018
Quantification of Efferocytosis by Single-cell Fluorescence Microscopy (Media)
Taruc, K., Yin, C., Wootton, D. G., & Heit, B. (2018). Quantification of Efferocytosis by Single-cell Fluorescence Microscopy. doi:10.3791/58149DOI: 10.3791/58149
Chakrabarti, B., Wootton, D. G., Lane, S., Kanwar, E., Somers, J., Proctor, J., . . . Woodhead, M. (2018). The association between pre-hospital antibiotic therapy and subsequent in-hospital mortality in adults presenting with community-acquired pneumonia: an observational study. Pneumonia, 10. doi:10.1186/s41479-018-0047-4DOI: 10.1186/s41479-018-0047-4
2017
A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days (Journal article)
Wootton, D. G., Dickinson, L., Pertinez, H., Court, J., Eneje, O., Keogan, L., . . . Diggle, P. J. (2017). A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days. European Respiratory Journal, 49(6). doi:10.1183/13993003.02170-2016DOI: 10.1183/13993003.02170-2016
2016
Wootton, D. G., Diggle, P. J., Court, J., Eneje, O., Keogan, L., Macfarlane, L., . . . Gordon, S. B. (2016). Recovery from pneumonia requires efferocytosis which is impaired in smokers and those with low body mass index and enhanced by statins. Thorax, 71(11), 1052-1054. doi:10.1136/thoraxjnl-2016-208505DOI: 10.1136/thoraxjnl-2016-208505
P214 Arrhythmias in pneumonia: a review of incidence, outcomes and management (vol 70, pg A184, 2015) (Presentation material)
Cox, D. R., Wootton, D. G., & Blakey, J. (2016). P214 Arrhythmias in pneumonia: a review of incidence, outcomes and management (vol 70, pg A184, 2015). doi:10.1136/thoraxjnl-2015-207770.350corr1DOI: 10.1136/thoraxjnl-2015-207770.350corr1
2015
The Genus Haemophilus Was Dominant In A Cohort With Community Acquired Pneumonia And Low Species Diversity Was Related To Age And Prior Pulmonary Disease (Conference Paper)
Wootton, D. G., Cox, M. J., Hickey, G. L., Eneje, O., Court, J., Macfarlane, L., . . . Gordon, S. B. (2015). The Genus Haemophilus Was Dominant In A Cohort With Community Acquired Pneumonia And Low Species Diversity Was Related To Age And Prior Pulmonary Disease. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Vol. 191. Retrieved from https://www.webofscience.com/
Household Air Pollution Causes Dose-Dependent Inflammation and Altered Phagocytosis in Human Macrophages (Journal article)
Rylance, J., Fullerton, D. G., Scriven, J., Aljurayyan, A. N., Mzinza, D., Barrett, S., . . . Gordon, S. B. (2015). Household Air Pollution Causes Dose-Dependent Inflammation and Altered Phagocytosis in Human Macrophages. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 52(5), 584-593. doi:10.1165/rcmb.2014-0188OCDOI: 10.1165/rcmb.2014-0188OC
Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation (Journal article)
Lim, W. S., Brittain, C., Duley, L., Edwards, S., Gordon, S., Montgomery, A., . . . Wootton, D. (2015). Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation. HEALTH TECHNOLOGY ASSESSMENT, 19(16), 1-+. doi:10.3310/hta19160DOI: 10.3310/hta19160
2014
The diagnosis of pneumonia requires a chest radiograph (x-ray)–yes, no or sometimes? (Journal article)
Wootton, D., & Feldman, C. (2014). The diagnosis of pneumonia requires a chest radiograph (x-ray)–yes, no or sometimes?. Pneumonia, 5(S1), 1-7. doi:10.15172/pneu.2014.5/464DOI: 10.15172/pneu.2014.5/464
Bronchoalveolar Lavage (BAL) for Research; Obtaining Adequate Sample Yield (Journal article)
Collins, A. M., Rylance, J., Wootton, D. G., Wright, A. D., Wright, A. K. A., Fullerton, D. G., & Gordon, S. B. (2014). Bronchoalveolar Lavage (BAL) for Research; Obtaining Adequate Sample Yield. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, (85). doi:10.3791/4345DOI: 10.3791/4345
Feasibility study for early supported discharge in adults with respiratory infection in the UK (Journal article)
Collins, A. M., Eneje, O. J., Hancock, C. A., Wootton, D. G., & Gordon, S. B. (2014). Feasibility study for early supported discharge in adults with respiratory infection in the UK. BMC PULMONARY MEDICINE, 14. doi:10.1186/1471-2466-14-25DOI: 10.1186/1471-2466-14-25
The pathophysiology of pneumococcal pneumonia (Chapter)
Wootton, D. G., Aston, S. J., & Gordon, S. B. (2014). The pathophysiology of pneumococcal pneumonia. In COMMUNITY-ACQUIRED PNEUMONIA (pp. 42-63). doi:10.1183/1025448x.10003313DOI: 10.1183/1025448x.10003313
2012
Supported home-care schemes: the key to increasing outpatient care? (Journal article)
Collins, A. M., Wilks, S., Wootton, D., & Gordon, S. B. (2012). Supported home-care schemes: the key to increasing outpatient care?. The European respiratory journal, 39(2), 508. doi:10.1183/09031936.00165911DOI: 10.1183/09031936.00165911
Using the BTS CAP audit to evaluate local data (Journal article)
Singh, B., Wootton, D. G., Brown, J., Chakrabarti, B., Cooke, R. P. D., & Gordon, S. B. (2012). Using the BTS CAP audit to evaluate local data. Thorax, 67(9), 832.1-832. doi:10.1136/thoraxjnl-2011-200876DOI: 10.1136/thoraxjnl-2011-200876
2011
P251 Junior doctors' interpretation of CXRs is more consistent than consultants in the context of possible pneumonia (Presentation material)
Singh, B., Curtis, J., Gordon, S. B., Diggle, P. J., & Wootton, D. G. (2011). P251 Junior doctors' interpretation of CXRs is more consistent than consultants in the context of possible pneumonia. doi:10.1136/thoraxjnl-2011-201054c.251DOI: 10.1136/thoraxjnl-2011-201054c.251
2009
Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria. (Journal article)
Miller, A. K., Bandyopadhyay, N., Wootton, D. G., Duparc, S., Kirby, P. L., Winstanley, P. A., & Ward, S. A. (2009). Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.. European journal of clinical pharmacology, 65(10), 977-987. doi:10.1007/s00228-009-0672-1DOI: 10.1007/s00228-009-0672-1
Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi (Journal article)
Bell, D. J., Wootton, D., Mukaka, M., Montgomery, J., Kayange, N., Chimpeni, P., . . . Lalloo, D. G. (2009). Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. MALARIA JOURNAL, 8. doi:10.1186/1475-2875-8-204DOI: 10.1186/1475-2875-8-204
2008
Wootton, D. G., Opara, H., Biagini, G. A., Kanjala, M. K., Duparc, S., Kirby, P. L., . . . Winstanley, P. A. (2008). Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria.. PloS one, 3(3), e1779. doi:10.1371/journal.pone.0001779DOI: 10.1371/journal.pone.0001779
2007
Austrian's syndrome: The first described case of pneumococcal meningitis pneumonia and endocarditis in an injecting drug user (Journal article)
Beadsworth, M. B. J., Wooton, D., Chenzbraun, A., & Beeching, N. J. (2007). Austrian's syndrome: The first described case of pneumococcal meningitis pneumonia and endocarditis in an injecting drug user. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 18(8), 605-606. doi:10.1016/j.ejim.2007.03.012DOI: 10.1016/j.ejim.2007.03.012
2006
Malaria: clinical features and recommended management (Journal article)
Wootton, D., Beeching, N., & Lalloo, D. (2006). Malaria: clinical features and recommended management. Prescriber, 17(21), 44-52. doi:10.1002/psb.437DOI: 10.1002/psb.437
Undated
Evolution of Long-Term Hybrid Immunity in Healthcare Workers after Different Covid-19 Vaccination Regimens: A Longitudinal Observational Cohort Study (Journal article)
Moore, S., Kronsteiner, B., Longet, S., Adele, S., Deeks, A., Liu, C., . . . Consortium, P. I. T. C. H. (n.d.). Evolution of Long-Term Hybrid Immunity in Healthcare Workers after Different Covid-19 Vaccination Regimens: A Longitudinal Observational Cohort Study.
Wootton, D. (n.d.). Recovery from community acquired pneumonia. (PhD Thesis, University of Liverpool).
Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine (Journal article)
Payne, R. P., Longet, S., Austin, J. A., Skelly, D., Dejnirattisai, W., Adele, S., . . . Consortium, T. P. I. T. C. H. (n.d.). Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine.
